Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 132 clinical trials
A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease

This study aims to define the efficacy and safety of inebilizumab for the prevention of flare of IgG4-related disease (IgG4-RD).

  • 0 views
  • 15 Apr, 2021
  • 85 locations
Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids

drugs called glucocorticoids (GCs) can calm down an overactive immune system. But they often cause negative side effects. Researchers want to learn how human genes respond to GCs. Genes live inside each

  • 0 views
  • 29 Apr, 2021
  • 1 location
Deflazacort vs. Prednisolone in Acute-stage ABPA

Oral glucocorticoids are currently the treatment of choice for allergic bronchopulmonary aspergillosis (ABPA). They not only suppress the immune hyperfunction but are also anti-inflammatory

  • 2 views
  • 28 Feb, 2021
  • 1 location
Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty

Preoperative quadratus lumborum block (QLB)/lateral femoral cutaneous nerve block (LFCNB) with ropivacaine and glucocorticoids provide more effective analgesia than periarticular injection (PAI

periarticular injection
analgesia
hip arthroplasty
nerve block
glucocorticoids
  • 0 views
  • 08 Mar, 2021
  • 1 location
Bioequivalence Study of Prednisolone and Dexamethasone

The purpose of this study is to compare two different glucocorticoids, prednisolone and dexamethasone at two different doses for their organ specific effects, utilizing modern day standards.

  • 0 views
  • 15 Apr, 2021
  • 1 location
Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.

glucocorticoids treatment. In a systematic review and meta-analysis, glucocorticoids regimen was the most significant variable explaining the variability between the proportions of ANCA-associated

  • 0 views
  • 23 Jan, 2021
  • 57 locations
Using A Novel Classification System in Intravenous GCs Therapy of TAO: A Multi-central Randomized Open Superior Trial

For patients with active moderate-to-severe thyroid associated ophthalmopathy (TAO), the Intravenous Glucocorticoids (GCs) is the recommended therapy. However, the efficacy of GCs is not

eye disease
glucocorticoids
  • 11 views
  • 21 Jan, 2021
Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population Admitted to a Geriatric Hospital Unit or in a Transicional Care Center

Study to compare the efficacy and safety of colchicine and glucocorticoids compared with the standard of treatment for moderate/severe COVID-19 in a fragile and vulnerable population, admitted

  • 0 views
  • 27 Jan, 2021
  • 3 locations
Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia

regrowth and relapse. Moreover, it has been experimentally shown that leukemic cells in acute myeloid leukemia patients who relapse become sensitive to glucocorticoids treatment highlighting a novel

  • 0 views
  • 25 Jan, 2021
  • 5 locations
Study of the Excretion of Orally Administered Corticosteroids for the Improval of the Detection of Said Substances in Anti-doping Controls

Background Glucocorticoids (GC) were included in the list of banned substances in sports in 1986, because of evidences of positive effects on physical performance

  • 0 views
  • 07 Apr, 2021
  • 1 location